Although baseline levels of MOTS-c did not show a direct correlation with conventional prognostic indices, the notably diminished levels following therapy in refractory patients imply a potential association with resistance mechanisms in MM. The gene discussed is MT-RNR1; the disease is Miyoshi myopathy.